San Jose, CA, United States of America

Ronald P Haak

This inventor holds 43 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Electrotransport Delivery. Top assignee: Alza Corporation. Active years: 1990-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald P Haak. Retrieved from https://idiyas.com/inventor/ronald-p-haak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 43 

% Patents Active = 95.3


Average Co-Inventor Count = 3.3

ph-index = 31

Forward Citations = 2,439(Granted Patents)


Location History:

  • Cupertino, CA (US) (1990 - 1994)
  • San Jose, CA (US) (1992 - 2001)
  • Palo Alto, CA (US) (1999 - 2007)
  • Menlo Park, CA (US) (1995 - 2010)

Company Filing History:


Years Active: 1990-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Electrotransport
Iontophoretic
Transdermal
Drug Delivery
Safety
Current Adjustment
Layered Membranes
Hydration
Adhesives
Control Membrane
Skin Sensitization
Indicator
43 patents (USPTO):Explore Patents

Title: Ronald P. Haak: Innovator in Electrotransport Delivery Devices

Introduction

Ronald P. Haak is a distinguished inventor based in San Jose, California, with an impressive portfolio of 43 patents. His work primarily focuses on innovations in electrotransport delivery devices, where he has made significant advancements aimed at improving safety and efficacy in delivering therapeutic agents through the skin.

Latest Patents

Among his latest contributions to the field are two notable patents. The first, titled "Electrotransport delivery device having improved safety and reduced abuse potential," describes a specialized electrotransport device designed to deliver therapeutic agents while ensuring better safety and less potential for misuse. The device features electrodes in contact with the skin, a power source for generating an electrical current, and various means for disabling the current permanently. These features include a timer, counter, or body parameter sensor that facilitate safe and controlled delivery.

The second patent, "Electrotransport agent delivery method and apparatus," outlines a method to enhance the delivery efficiency of agents through body surfaces. This method applies electrotransport current at higher density values for specific durations, followed by lower current densities, ultimately transforming the body surface to achieve a more effective agent delivery state.

Career Highlights

Ronald Haak has been a key contributor at Alza Corporation, where he has played an integral role in progressing the field of electrotransport technology. His innovative approaches and solutions have not only led to multiple patents but have also paved the way for newer biomedical applications.

Collaborations

Throughout his career, Haak has collaborated with prominent figures in the field, including Felix T. Theeuwes and J. Richard Gyory. These partnerships have enabled cross-pollination of ideas and techniques, further enriching the innovative culture at Alza Corporation.

Conclusion

Ronald P. Haak stands out as a pioneer in the development of electrotransport delivery devices, with a focus on safety and efficiency. His extensive patent portfolio and collaborative efforts highlight his dedication to advancing technology in the biomedical field, making him a significant figure in modern innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…